These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 37156775)
1. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation. Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775 [TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738 [TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA LINC00200 promotes the malignant progression of MYCN-amplified neuroblastoma via binding to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) to enhance the stability of Zic family member 2 (ZIC2) mRNA. Chen J; Sun M; Huang L; Fang Y Pathol Res Pract; 2022 Sep; 237():154059. PubMed ID: 35969939 [TBL] [Abstract][Full Text] [Related]
4. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma. Du M; Peng Y; Li Y; Sun W; Zhu H; Wu J; Zong D; Wu L; He X Cell Death Discov; 2022 Feb; 8(1):53. PubMed ID: 35136045 [TBL] [Abstract][Full Text] [Related]
5. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103 [TBL] [Abstract][Full Text] [Related]
6. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m Yang Y; Zhang Y; Chen G; Sun B; Luo F; Gao Y; Feng H; Li Y J Exp Clin Cancer Res; 2024 May; 43(1):141. PubMed ID: 38745192 [TBL] [Abstract][Full Text] [Related]
7. m Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589 [TBL] [Abstract][Full Text] [Related]
8. IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner. Zhang X; Shi L; Sun HD; Wang ZW; Xu F; Wei JF; Ding Q Clin Transl Med; 2023 Sep; 13(9):e1427. PubMed ID: 37743642 [TBL] [Abstract][Full Text] [Related]
9. N Zheng X; Li S; Yu J; Dai C; Yan S; Chen G; Sun C Transl Cancer Res; 2023 Apr; 12(4):992-1005. PubMed ID: 37180667 [TBL] [Abstract][Full Text] [Related]
10. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc. Jin W; Yao Y; Fu Y; Lei X; Fu W; Lu Q; Tong X; Xu Q; Su W; Hu X Cell Mol Biol Lett; 2024 Jul; 29(1):97. PubMed ID: 38961325 [TBL] [Abstract][Full Text] [Related]
11. SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. Tan K; Mo J; Li M; Dong Y; Han Y; Sun X; Ma Y; Zhu K; Wu W; Lu L; Liu J; Zhao K; Zhang L; Tang Y; Lv Z J Exp Clin Cancer Res; 2022 Dec; 41(1):352. PubMed ID: 36539767 [TBL] [Abstract][Full Text] [Related]
12. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway. Ban Z; Li Z; Xing S; Ye Y PLoS One; 2024; 19(5):e0303593. PubMed ID: 38820515 [TBL] [Abstract][Full Text] [Related]
13. IGF2BP3 suppresses ferroptosis in lung adenocarcinoma by m6A-dependent regulation of TFAP2A to transcriptionally activate SLC7A11/GPX4. Li P; Chu D; Ding G; Qin D; Bu Y; Tian B Mol Cell Biochem; 2024 Jul; ():. PubMed ID: 39026029 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer. Jiang L; Li Y; He Y; Wei D; Yan L; Wen H Front Oncol; 2021; 11():711207. PubMed ID: 34621671 [TBL] [Abstract][Full Text] [Related]
15. IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization. Qin J; Cui Z; Zhou J; Zhang B; Lu R; Ding Y; Hu H; Cai J Transl Oncol; 2023 Nov; 37():101764. PubMed ID: 37643553 [TBL] [Abstract][Full Text] [Related]
16. IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N Zhang J; Yang K; Bu J; Yan J; Hu X; Liu K; Gao S; Tang S; Gao L; Chen W Front Oncol; 2022; 12():1035871. PubMed ID: 36313631 [TBL] [Abstract][Full Text] [Related]
17. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma. Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046 [TBL] [Abstract][Full Text] [Related]
19. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification. Xu Y; Chen X; Lin L; Chen H; Yu S; Li D Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]